Evidence map›Paper›PMID 42404911›Full record

ArticleAAPS open2026

Machine learning guided optimization of an oral microemulsion system: a Bayesian optimization approach.

Madeline Gunawardena, Bao Chau, Hayden Nothacker, Rudra Pangeni, Thomas Roper, Qingguo Xu, Charles McGill

Abstract read
In one paragraph

Article in AAPS open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Madeline Gunawardena *Department of Pharmaceutics, School of Pharmacy, Virginia Commonwealth University, Richmond, VA 23298 USA.
Bao Chau *Department of Chemical and Life Science Engineering, College of Engineering, Virginia Commonwealth University, Richmond, VA 23219 USA.
Hayden NothackerDepartment of Chemical and Life Science Engineering, College of Engineering, Virginia Commonwealth University, Richmond, VA 23219 USA.
Rudra PangeniDepartment of Pharmaceutics, School of Pharmacy, Virginia Commonwealth University, Richmond, VA 23298 USA.
Thomas RoperDepartment of Chemical and Life Science Engineering, College of Engineering, Virginia Commonwealth University, Richmond, VA 23219 USA.
Qingguo XuDepartment of Pharmaceutics, School of Pharmacy, Virginia Commonwealth University, Richmond, VA 23298 USA.ORCID 0000-0003-3191-0771
Charles McGillDepartment of Chemical and Life Science Engineering, College of Engineering, Virginia Commonwealth University, Richmond, VA 23219 USA.

Funding

Sustained release of fenofibrate for the treatment of diabetic retinopathyR01EY033477 · NEI · VIRGINIA COMMONWEALTH UNIVERSITY · PI Jian-Xing Jay Ma, QINGGUO XU · 2022 to 2026
$2.7M
Fenofibrate microemulsion for treating nitrogen mustard induced corneal injuryUG3EY036558 · NEI · VIRGINIA COMMONWEALTH UNIVERSITY · PI Jian-Xing Jay Ma, QINGGUO XU · 2025 to 2026
$1.1M
NEI NIH HHS R01 EY033477NEI NIH HHS UG3 EY036558NSF 2136518
6 · The paper itself

Abstract

Oral microemulsions are one drug delivery system often implemented to improve intestinal permeability and oral bioavailability of poorly water-soluble drugs. They also present several practical advantages including high patient compliance and simplified manufacturing methods which contribute to their promise as marketable drug products. Despite these advantages, however, the microemulsion formulation development process is extremely time consuming and resource intensive, typically involving extensive screening of components and excessive preliminary trials in order to achieve stable formulations. As a result, MEs are often suboptimal in their therapeutic performance, and there is an unmet need for improved methods to streamline microemulsion formulation design. In this work, a batch Bayesian Optimization strategy was used to design a subset of unique in-specification microemulsions with highly optimized physicochemical properties in five iterations containing batches of five experiments. A two-phase modeling approach was developed to achieve this goal and allowed for navigating a complex experimental design space, including multiple oils, surfactants, cosurfactants, and processing parameters with an initial training dataset consisting of 22 experiments. As a result of this study, five high-performing blank microemulsions were identified, and four of them exhibited physical stability upon storage for up to 30 days. Further, when loaded with two different model drug candidates, three of the microemulsions achieved high drug loading, acceptable stability and improved in-vitro permeability, highlighting their promise for potential translation to later stages of development. Supplementary Information: The online version contains supplementary material available at 10.1186/s41120-026-00176-0.

Indexed as

Drug formulation developmentOral drug deliveryPhysicochemical regressionProperty predictionStability classification

Identifiers

PMID42404911
PMCPMC13328243

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.